Kelden Sciences Retatrutide 40 mg vial on a white background

.pro-gallery-wix-wrapper {display: block !important;} .pro-gallery-wix-wrapper .gallery-item-container {opacity: 1 !important; display: block !important;}

Retatrutide 40mg

Name: Retatrutide 40mg
Brand: Kelden Peptides Canada
Price: 205 CAD
Availability: InStock
Rating: 5 (1 reviews)

Rating is 5.0 out of five stars based on 1 review

Original price

$220.00

Sale price

$205.00

Retatrutide 40mg is Kelden Peptides Canada’ higher-strength Retatrutide research format. Retatrutide is an investigational triple-receptor peptide designed to interact with GLP-1, GIP and glucagon receptor pathways and is also known by the research identifier LY3437943.

Its three-pathway receptor profile has made Retatrutide a widely studied compound in metabolic signaling research, particularly when researchers want to compare triple-receptor activity with single- or dual-incretin systems.

The 40mg format is suited to research environments requiring a higher total quantity of material while maintaining the same compound identity. Lower-strength Retatrutide 10mg, Retatrutide 20mg and Retatrutide 30mg formats are also available.

Researchers can review Kelden Peptides Canada’ lab reports and testing information or use the peptide dosage calculator for laboratory concentration calculations. For research use only.

Quantity

Research & Product Details

Compound: Retatrutide Also known as: LY3437943 Form: Lyophilized research peptide Strength: 40mg Research category: GLP-1 / GIP / glucagon triple-receptor research peptide Research overview: Retatrutide is an investigational triple-receptor peptide developed to engage GLP-1, GIP and glucagon receptor pathways. Laboratory interest centers on the interaction of these three metabolic signaling systems and how combined receptor activity differs from single- or dual-incretin models. The 40mg format is the highest-strength Retatrutide option in the current Kelden Peptides Canada catalog, allowing projects that require a larger total amount of the same research compound while maintaining the same underlying molecular identity. Documentation: Published laboratory records are listed separately where available. Batch-specific testing and batch numbers can be added to this section once verified.